Related references
Note: Only part of the references are listed.Kappa free light chain index as a diagnostic biomarker in multiple sclerosis: A real-world investigation
Igal Rosenstein et al.
JOURNAL OF NEUROCHEMISTRY (2021)
B cells in multiple sclerosis - from targeted depletion to immune reconstitution therapies
Maria T. Cencioni et al.
NATURE REVIEWS NEUROLOGY (2021)
Effects of Natalizumab Therapy on Intrathecal Immunoglobulin G Production Indicate Targeting of Plasmablasts
Miriam Schlueter et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2021)
The Influence of Renal Function Impairment on Kappa Free Light Chains in Cerebrospinal Fluid
Franz F. Konen et al.
JOURNAL OF CENTRAL NERVOUS SYSTEM DISEASE (2021)
Controversy on the treatment of multiple sclerosis and related disorders: positional statement of the expert panel in charge of the 2021 DGN Guideline on diagnosis and treatment of multiple sclerosis, neuromyelitis optica spectrum diseases and MOG-IgG-associated disorders
A. Bayas et al.
NEUROLOGICAL RESEARCH AND PRACTICE (2021)
Kappa free light chains is a valid tool in the diagnostics of MS: A large multicenter study
C. E. Leurs et al.
MULTIPLE SCLEROSIS JOURNAL (2020)
Alemtuzumab therapy changes immunoglobulin levels in peripheral blood and CSF
Nora Moehn et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2020)
Free light chain kappa and the polyspecific immune response in MS and CIS - Application of the hyperbolic reference range for most reliable data interpretation
Marie Suesse et al.
JOURNAL OF NEUROIMMUNOLOGY (2020)
Systemic Effects by Intrathecal Administration of Triamcinolone Acetonide in Patients With Multiple Sclerosis
Andreas Hoeflich et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Intrathecal kappa free light chains as markers for multiple sclerosis
D. Vecchio et al.
SCIENTIFIC REPORTS (2020)
Modification of CSF findings in multiple sclerosis in the era of rapidly expanding treatment options
Ioanna Giotaki et al.
EXPERT REVIEW OF NEUROTHERAPEUTICS (2019)
Association of Intrathecal Immunoglobulin G Synthesis With Disability Worsening in Multiple Sclerosis
Christiane Gasperi et al.
JAMA NEUROLOGY (2019)
Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis
Catherina Pfuhl et al.
NEUROLOGY (2019)
Effects of natalizumab therapy on intrathecal antiviral antibody responses in MS
Fabienne Largey et al.
NEUROLOGY-NEUROIMMUNOLOGY & NEUROINFLAMMATION (2019)
Diagnostic relevance of free light chains in cerebrospinal fluid - The hyperbolic reference range for reliable data interpretation in quotient diagrams
Hansotto Reiber et al.
CLINICA CHIMICA ACTA (2019)
Reiber's Diagram for Kappa Free Light Chains: The New Standard for Assessing Intrathecal Synthesis?
Philipp Schwenkenbecher et al.
DIAGNOSTICS (2019)
Inflammatory intrathecal profiles and cortical damage in multiple sclerosis
Roberta Magliozzi et al.
ANNALS OF NEUROLOGY (2018)
Disease-modifying treatments for early and advanced multiple sclerosis: a new treatment paradigm
Gavin Giovannoni
CURRENT OPINION IN NEUROLOGY (2018)
Kappa free light chains in cerebrospinal fluid to identify patients with oligoclonal bands
M. Suesse et al.
EUROPEAN JOURNAL OF NEUROLOGY (2018)
Applying the 2017 McDonald diagnostic criteria for multiple sclerosis
Philipp Schwenkenbecher et al.
LANCET NEUROLOGY (2018)
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Alan J. Thompson et al.
LANCET NEUROLOGY (2018)
The Persisting Significance of Oligoclonal Bands in the Dawning Era of Kappa Free Light Chains for the Diagnosis of Multiple Sclerosis
Philipp Schwenkenbecher et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Clinically Isolated Syndrome According to McDonald 2010: Intrathecal IgG Synthesis Still Predictive for Conversion to Multiple Sclerosis
Philipp Schwenkenbecher et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
Multiple sclerosis: assay of free immunoglobulin light chains
D. B. Ramsden
ANNALS OF CLINICAL BIOCHEMISTRY (2017)
Inclusion of brain volume loss in a revised measure of no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
Inclusion of brain volume loss in a revised measure of no evidence of disease activity' (NEDA-4) in relapsing-remitting multiple sclerosis
Ludwig Kappos et al.
MULTIPLE SCLEROSIS JOURNAL (2016)
The effects of intrathecal rituximab on biomarkers in multiple sclerosis
Joanne Topping et al.
MULTIPLE SCLEROSIS AND RELATED DISORDERS (2016)
Natalizumab exerts a suppressive effect on surrogates of B cell function in blood and CSF
Clemens Warnke et al.
MULTIPLE SCLEROSIS JOURNAL (2015)
Peripheral B cell depletion and central proinflammatory cytokine reduction following repeated intrathecal administration of rituximab in progressive Multiple Sclerosis
Valeria Studer et al.
JOURNAL OF NEUROIMMUNOLOGY (2014)
Determination of kFLC and K Index in cerebrospinal fluid: A valid alternative to assessintrathecal immunoglobulin synthesis
Fabio Duranti et al.
JOURNAL OF NEUROIMMUNOLOGY (2013)
Cerebrospinal fluid parameters of B cell-related activity in patients with active disease during natalizumab therapy
A. Harrer et al.
MULTIPLE SCLEROSIS JOURNAL (2013)
Disappearance of cerebrospinal fluid oligoclonal bands after natalizumab treatment of multiple sclerosis patients
Felipe von Glehn et al.
MULTIPLE SCLEROSIS JOURNAL (2012)
Diagnostic Criteria for Multiple Sclerosis: 2010 Revisions to the McDonald Criteria
Chris H. Polman et al.
ANNALS OF NEUROLOGY (2011)
Free immunoglobulin light chain: Its biology and implications in diseases
Takanari Nakano et al.
CLINICA CHIMICA ACTA (2011)
Differential effects of fingolimod (FTY720) on immune cells in the CSF and blood of patients with MS
M. C. Kowarik et al.
NEUROLOGY (2011)
Immunoglobulin Free Light Chain Dimers in Human Diseases
Batia Kaplan et al.
THESCIENTIFICWORLDJOURNAL (2011)
Changes in B- and T-Lymphocyte and Chemokine Levels With Rituximab Treatment in Multiple Sclerosis
Laura Piccio et al.
ARCHIVES OF NEUROLOGY (2010)
Rituximab reduces B cells and T cells in cerebrospinal fluid of multiple sclerosis patients
Anne H. Cross et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Diagnostic criteria for multiple sclerosis: 2005 Revisions to the McDonald Criteria
CH Polman et al.
ANNALS OF NEUROLOGY (2005)
Mast cells: new targets for multiple sclerosis therapy?
JP Zappulla et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
Share Paper
